A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
This study is ongoing, but not recruiting participants.
Study NCT01271790
Information provided by Gilead Sciences
First Received on January 5, 2011.
Last Updated on March 1, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
